This panel will illustrate a psychoanalytic response to the politics of the day. One panelist will describe how two immigrant analysts responded to political upheaval in America. A second will describe the response to the AIDS crisis in the 1980’s…
The Ralph Roughton Award is given to an unpublished manuscript that makes an original and outstanding contribution to the psychoanalytic understanding and or treatment of LGBTQ* people. This 2025 Roughton award winning paper brings into focus the similar ways in…
As independent psychoanalysts from the British Society, the presenters feel a distinctive identity and aim to articulate the important aspects of their theory and clinical technique and its roots. They have developed their way of working drawing on the contributions…
More effective treatment options for Missouri adults and youth with obesity are available than ever before. This training will familiarize healthcare professionals with intensive/family-based behavioral treatment and medication therapy for patients with obesity. The session will review health behavior changes…
Board-certified physician at Stanford Medicine, Smita Das, MD, PhD, MPH, and professor and director of Addiction Sciences at the Medical University of South Carolina, Kevin Gray, MD, discuss cannabis use and its effects on mental health and psychiatric disorders, including…
Inequities in health care and medical education have a long and complex history involving racism, sexism, ableism, exclusivity, and other forms of social injustice. In November 2024, the American Medical Association published an externally commissioned book, Reimagining Medical Education: The…
Board-certified physician at Stanford Medicine, Smita Das, MD, PhD, MPH, and professor and director of Addiction Sciences at the Medical University of South Carolina, Kevin Gray, MD, discuss cannabis use and its effects on mental health and psychiatric disorders, including…
The US Food and Drug Administration has approved cannabis-derived medications for several indications. In this episode, family practitioner Randy Easterling, MD, highlights the current regulatory status of FDA-approved cannabis-derived medications and their approved uses.
The US Food and Drug Administration has approved cannabis-derived medications for several indications. In this episode, family practitioner Randy Easterling, MD, highlights the current regulatory status of FDA-approved cannabis-derived medications and their approved uses.
No business owner, let alone a physician focused on patient care, anticipates running afoul of legal or regulatory issues. Being aware, informed, and prepared cannot be emphasized enough.
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
